3 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 3 |
Follow Neoplasms, Second Primary: new trials by email Literature Review of Neoplasms, Second Primary trials Research Report on Neoplasms, Second Primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI Doxycycline 100mg po once daily x 6 months, Isotretinoin 40 mg po once daily x 6 months - Acneiform Eruptions, Cancer, Treatment-Related | Phase 4 | Unknown | Lady Davis Institute | 98 | 2021-09-01 | 2021-09-08 |
| The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol Chemotherapy drugs, thalidomide and megestrol acetate, optimal support treatment - Cancer, Therapy-Related | Phase 4 | Unknown | Shenzhen Fifth People's Hospital | 200 | 2018-12-10 | 2018-12-19 |
| Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation Icotinib, chemotherapy (Carboplatin and Docetaxel) - Neoplasms, Therapy-Associated | Phase 4 | Unknown | Chinese PLA General Hospital | 10 | 2014-10-01 | 2014-11-05 |
Acneiform Eruptions (1) · Neoplasms (1)
Neoplasms (2) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Antineoplastic Agents (1) · Carboplatin (1) · Docetaxel (1) · Doxycycline (1) · Drug Therapy (1) · Isotretinoin (1) · Megestrol Acetate (1) · Thalidomide (1) · icotinib (1)
Chinese PLA General Hospital (1) · Lady Davis Institute (1) · Shenzhen Fifth People's Hospital (1)
Canada (1) · China (1)
Yang Liu, doctor (1)